| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e28bc47417a2bf3f69112a6130236f7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d77148b200d14a99fec87084a6c9c2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a7f3068c412965d1d753bd152f94fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142 |
| filingDate |
2020-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65bb501d873cfc97c45c984193b408f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9a665dc4e3143f593a2d94b101fa13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2f8640e40f8ae8b0533e2e8a5033f70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f6eb51c6ce5263bea203cc7df70fdc5 |
| publicationDate |
2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020203126-A1 |
| titleOfInvention |
Pharmaceutical solution comprising dopamine for use in treating Parkinson's disease |
| abstract |
Abstract The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under 5 anaerobic conditions from its formulation to its administration. |
| priorityDate |
2014-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |